Product NDC: | 0168-0202 |
Proprietary Name: | clindamycin phosphate |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 10 mg/g & nbsp; clindamycin phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0202 |
Labeler Name: | E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA064160 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100128 |
Package NDC: | 0168-0202-30 |
Package Description: | 1 TUBE in 1 CARTON (0168-0202-30) > 30 g in 1 TUBE |
NDC Code | 0168-0202-30 |
Proprietary Name | clindamycin phosphate |
Package Description | 1 TUBE in 1 CARTON (0168-0202-30) > 30 g in 1 TUBE |
Product NDC | 0168-0202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20100128 |
Marketing Category Name | ANDA |
Labeler Name | E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc. |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |